PubMed · 10099295
Microporous microparticles designed as stable immunoadsorbents.
Abstract
We have developed a solid-phase immunoadsorbent based on encapsulated goat anti-apolipoprotein B polyclonal antibodies previously crosslinked with a 0.25% glutaraldehyde solution, and designed to remove by immunoaffinity the excess of apolipoproteins B from the plasma of patients affected by familial hypercholesterolemia. Compared to a classical immunoadsorbent prepared by activation of Sepharose CL-4B with cyanogen bromide, the resulting immunoadsorbent exhibits both optimal adsorption capacity and stability over the entire range of chemical and biochemical conditions during its practical handling. This approach will serve as a model system to demonstrate the applicability of microparticles as immunoadsorbents, which can be achieved for other encapsulated crosslinked proteins.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
N Ubrich, C Rivat, C Vigneron, P Maincent. 1998-06-20. Microporous microparticles designed as stable immunoadsorbents.. https://searchpubmed.org/record/pubmed%3A10099295/microporous-microparticles-designed-as-stable-immunoadsorbents
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite Search PubMed by Indiciae: BibTeX · RIS.